News 2018-05-21T17:02:04+02:00
2807, 2022

CHARM, the EU project we partnered started developing its work program in May 2022

July 28th, 2022|Tags: , , |0 Comments

Even though the consortium started working on the project in May, we had our official Kick-off meeting with all the team and the EU officer on June 9, 2022. 🏥🧬 CHARM will radically transform cancer diagnosing process and bring the emerging field of digital histopathology to [...]

3006, 2022

Our CEO, Alfredo Sánchez, participated in AgriTech Nordic as one of their professional speakers

June 30th, 2022|Tags: , , |0 Comments

AgriTech Nordic is an initiative by T:Lab, Trønder-Avisa and Steinkjerfestivalen located in Steinkjer, Norway. Together with a broad specter of collaborators, their purpose is to contribute to innovation where new technology intersects with the agricultural, forestal, and aquacultural industry based out of the region [...]

2605, 2022

Europartner: the secrets behind the Business Partner that became Inspiralia’s family

May 26th, 2022|Tags: , , |0 Comments

Earlier this year, Europartner became a shareholder of our company, completing another step after thirteen years of a prosperous relationship and multiple collaborations. We decided to interview Edoardo Lucini, a Consultant and Business Developer in this company. Europartner was born in 1990 as a [...]

1105, 2022

m27 Finance and M27 Fedas merge to form Inspiralia GmbH to strengthen their presence and services in the DACH-region

May 11th, 2022|Tags: , , |0 Comments

The two established players and Inspiralia Group companies, m27 Finance and M27 Fedas are merging to form Inspiralia GmbH. The merge marks the culmination process of their cooperation with Inspiralia S.L, which started in 2015. Both funding and financing experts have already been active [...]

505, 2022

WEBINAR: How to Access EU funding for Health innovations

May 5th, 2022|Tags: , , |0 Comments

 Inspiralia partnered with Grannenfelt Finance to organize a webinar about the latest EU innovation and expansion funding for companies (large and small). On this occasion, we will focus on financing for companies within health applications (incl. technology or digital solution or medical devices). The entire development curve, [...]